About Tear Film Innovations
Tear Film Innovations is a company based in San Diego (United States) founded in 2012 was acquired by Alcon in December 2018.. Tear Film Innovations has raised $17.72 million across 2 funding rounds from investors including Alcon, Visionary Ventures and Bluestem. Tear Film Innovations offers products and services including Systane iLux 2 and Alcon Contact Lenses. Tear Film Innovations operates in a competitive market with competitors including Oculeve, TearScience, Bruder Healthcare, Olympic Ophthalmics and Sinopsys Surgical, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tear Film Innovations
Tear Film Innovations offers a comprehensive portfolio of products and services, including Systane iLux 2 and Alcon Contact Lenses. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for treating Meibomian Gland Dysfunction to relieve dry eye.
Lenses for daily, weekly, and monthly wear to improve eye comfort.
Funding Insights of Tear Film Innovations
Tear Film Innovations has successfully raised a total of $17.72M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8.5 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $8.5M
-
First Round
First Round
(07 Nov 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Series B - Tear Film Innovations | Valuation | Visionary Ventures , Bluestem Capital |
|
| Nov, 2017 | Amount | Series A - Tear Film Innovations | Valuation | Visionary Ventures , Tigris Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tear Film Innovations
Tear Film Innovations has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Visionary Ventures and Bluestem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Bluestem is recognized as a Midwest private equity company.
|
Founded Year | Domain | Location | |
|
Tigris Ventures is engaged in seed stage venture investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tear Film Innovations
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tear Film Innovations
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tear Film Innovations Comparisons
Competitors of Tear Film Innovations
Tear Film Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oculeve, TearScience, Bruder Healthcare, Olympic Ophthalmics and Sinopsys Surgical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A non-invasive nasal device for dry eye treatment is developed.
|
|
| domain | founded_year | HQ Location |
Devices for evaporative dry eye diagnosis and treatment are developed.
|
|
| domain | founded_year | HQ Location |
Solutions for dry eye and pain management are developed.
|
|
| domain | founded_year | HQ Location |
Provider and developer of tear production device for treatments of dry eye disease
|
|
| domain | founded_year | HQ Location |
Offers lacrimal stents and procedures designed to effectively treat sinusitis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tear Film Innovations
Frequently Asked Questions about Tear Film Innovations
When was Tear Film Innovations founded?
Tear Film Innovations was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Where is Tear Film Innovations located?
Tear Film Innovations is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Tear Film Innovations a funded company?
Tear Film Innovations is a funded company, having raised a total of $17.72M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.22M, raised on Nov 07, 2017.
What does Tear Film Innovations do?
Tear Film Innovations was founded in 2012 in San Diego, United States, focusing on medical devices for eye care. Products such as the iLux device and BlephaRx line are developed to address evaporative dry eye, meibomian gland dysfunction, and blepharitis. The iLux applies controlled heat to eyelids to liquefy meibum, while investigations proceed under FDA Investigational Device Exemption status, with no commercial availability yet.
Who are the top competitors of Tear Film Innovations?
Tear Film Innovations's top competitors include Oculeve, TearScience and Bruder Healthcare.
What products or services does Tear Film Innovations offer?
Tear Film Innovations offers Systane iLux 2 and Alcon Contact Lenses.
Who are Tear Film Innovations's investors?
Tear Film Innovations has 4 investors. Key investors include Alcon, Visionary Ventures, Bluestem, and Tigris Ventures.